GB Sciences’ Competitive Advantages

GB Sciences has several advantages over both pharmaceutical companies and academic researchers when it comes to the discovery and validation of new drug formulations from cannabis-derived compounds.

GB Sciences’ Patient Groups

Through its wholly-owned subsidiary, Growblox Life Sciences, LLC, GB Sciences has filed three provisional patent applications containing formulations to tackle the following conditions.

GB Sciences' Patents

GB Science has applied for patent protection of its cannabis-based formulations targeting various chronic conditions and diseases. Check back often for updates on current application and new applications.